Cargando…
False discovery rate control in cancer biomarker selection
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Chongqing Medical University
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311086/ https://www.ncbi.nlm.nih.gov/pubmed/37397555 http://dx.doi.org/10.1016/j.gendis.2022.12.010 |
| _version_ | 1785066670103986176 |
|---|---|
| author | Li, Zhaoming |
| author_facet | Li, Zhaoming |
| author_sort | Li, Zhaoming |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10311086 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Chongqing Medical University |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103110862023-07-01 False discovery rate control in cancer biomarker selection Li, Zhaoming Genes Dis Correspondence Chongqing Medical University 2023-01-20 /pmc/articles/PMC10311086/ /pubmed/37397555 http://dx.doi.org/10.1016/j.gendis.2022.12.010 Text en © 2023 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Correspondence Li, Zhaoming False discovery rate control in cancer biomarker selection |
| title | False discovery rate control in cancer biomarker selection |
| title_full | False discovery rate control in cancer biomarker selection |
| title_fullStr | False discovery rate control in cancer biomarker selection |
| title_full_unstemmed | False discovery rate control in cancer biomarker selection |
| title_short | False discovery rate control in cancer biomarker selection |
| title_sort | false discovery rate control in cancer biomarker selection |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311086/ https://www.ncbi.nlm.nih.gov/pubmed/37397555 http://dx.doi.org/10.1016/j.gendis.2022.12.010 |
| work_keys_str_mv | AT lizhaoming falsediscoveryratecontrolincancerbiomarkerselection |